A Loxo Oncology Inc drug shown to be effective against a wide variety of cancers driven by a single, rare genetic mutation has won U.S. approval, the Food and Drug Administration announced on Monday.
Loxo, Bayer drug for cancers driven by rare mutation gets U.S. nod
Reviewed by jenisht
on
November 27, 2018
Rating: 5
No comments: